KSH01-TCRT Solid Tumors

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 19, 2022

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2027

Conditions

TCR-T CellsRefractory Solid TumorsRelapsed Solid Tumors

Interventions

DRUG

KSH01 injection

TCR-T cell injection

Trial Locations (1)

RECRUITING

The first affiliated hospital of Guang Xi medical university, Nanning

All Listed Sponsors

lead

TCRx Therapeutics Co.Ltd

INDUSTRY